The stock of Alector Inc (ALEC) has gone up by 3.45% for the week, with a -2.44% drop in the past month and a -26.83% drop in the past quarter. The volatility ratio for the week is 6.88%, and the volatility levels for the past 30 days are 10.14% for ALEC. The simple moving average for the past 20 days is 13.81% for ALEC’s stock, with a -63.70% simple moving average for the past 200 days.
Is It Worth Investing in Alector Inc (NASDAQ: ALEC) Right Now?
ALEC has 36-month beta value of 0.76. Analysts have mixed views on the stock, with 5 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 1 as “sell.”
The public float for ALEC is 75.62M, and currently, short sellers hold a 7.38% ratio of that float. The average trading volume of ALEC on May 01, 2025 was 700.16K shares.
ALEC) stock’s latest price update
The stock of Alector Inc (NASDAQ: ALEC) has increased by 6.19 when compared to last closing price of 1.13.Despite this, the company has seen a gain of 3.45% in its stock price over the last five trading days. globenewswire.com reported 2025-04-17 that –76-week trial is evaluating the safety and efficacy of a progranulin-elevating candidate in slowing disease progression– –Enrollment completed ahead of schedule– SOUTH SAN FRANCISCO, Calif., April 17, 2025 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced the completion of enrollment in PROGRESS-AD, a 76-week Phase 2 clinical trial evaluating the safety and efficacy of AL101/GSK4527226 in slowing disease progression in individuals with early Alzheimer’s disease (AD).
Analysts’ Opinion of ALEC
Many brokerage firms have already submitted their reports for ALEC stocks, with Mizuho repeating the rating for ALEC by listing it as a “Neutral.” The predicted price for ALEC in the upcoming period, according to Mizuho is $2.50 based on the research report published on December 17, 2024 of the previous year 2024.
Stifel, on the other hand, stated in their research note that they expect to see ALEC reach a price target of $4. The rating they have provided for ALEC stocks is “Hold” according to the report published on December 16th, 2024.
BofA Securities gave a rating of “Underperform” to ALEC, setting the target price at $1 in the report published on December 04th of the previous year.
ALEC Trading at -8.35% from the 50-Day Moving Average
After a stumble in the market that brought ALEC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -82.30% of loss for the given period.
Volatility was left at 10.14%, however, over the last 30 days, the volatility rate increased by 6.88%, as shares surge +3.45% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -31.82% lower at present.
During the last 5 trading sessions, ALEC rose by +3.45%, which changed the moving average for the period of 200-days by -78.34% in comparison to the 20-day moving average, which settled at $1.0545. In addition, Alector Inc saw -36.51% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALEC starting from Kenkare-Mitra Sara, who sale 29,073 shares at the price of $1.47 back on Mar 03 ’25. After this action, Kenkare-Mitra Sara now owns 536,142 shares of Alector Inc, valued at $42,662 using the latest closing price.
Rosenthal Arnon, the Chief Executive Officer of Alector Inc, sale 40,330 shares at $1.47 during a trade that took place back on Mar 03 ’25, which means that Rosenthal Arnon is holding 2,466,744 shares at $59,176 based on the most recent closing price.
Stock Fundamentals for ALEC
Current profitability levels for the company are sitting at:
- -1.44 for the present operating margin
- 0.93 for the gross margin
The net margin for Alector Inc stands at -1.18. The total capital return value is set at -0.42. Equity return is now at value -91.24, with -21.84 for asset returns.
Based on Alector Inc (ALEC), the company’s capital structure generated 0.25 points at debt to capital in total, while cash flow to debt ratio is standing at -5.41.
Currently, EBITDA for the company is -136.16 million with net debt to EBITDA at -0.07. When we switch over and look at the enterprise to sales, we see a ratio of 1.29. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.40.
Conclusion
To put it simply, Alector Inc (ALEC) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
